All Episodes

G.I. E30: Anal Response, Surveillance, Toxicity, Salvage, and Future Directions.

G.I. E29: Anal IMRT Planning: Simulation, Contouring, Dose Painting, and Special Populations.

G.I. E28: Anal Chemoradiation: Chemotherapy, Dose, Timing, and Evidence.

G.I. E27: Anal Cancer Foundations: Anatomy, Staging, Workup, and the Nigro Paradigm.

G.I. E26: Rectal Planning, Pelvic Recurrence, Reirradiation, Toxicity, and Survivorship.

G.I. E25: Rectal Organ Preservation: Watch-and-Wait and dMMR Immunotherapy.

G.I. E24: Selective Radiation Omission: PROSPECT, Upfront Surgery, and Local Excision.

G.I. E23: Total Neoadjuvant Therapy: RAPIDO, PRODIGE 23, STELLAR, and OPRA.

G.I. E22: Rectal Neoadjuvant Radiation: Long Course, Short Course, and Surgical Timing.

G.I. E21: Rectal Cancer Foundations: MRI Staging, Anatomy, TME, and Risk Stratification.

G.I. E20: Rare GI Malignancies: Small Bowel, Duodenum, Appendix, GIST, and Neuroendocrine Tumors.

G.I. E19: Colorectal Oligometastases: Liver and Lung Surgery, Ablation, SBRT, and COLLISION.

G.I. E18: Metastatic Colorectal Cancer: Molecular Selection and Systemic Therapy.

G.I. E17: Localized Colon Cancer: Staging, Surgery, Adjuvant Therapy, and the Limited Role of Radiation.

G.I. E16: Advanced Biliary Tract Cancer: Systemic Therapy, Biomarkers, and Local Therapy.

G.I. E15: Resectable Biliary Tract Cancer: Surgery, Adjuvant Therapy, and Radiation.

G.I. E14: HCC Radiation: EBRT, SBRT, Protons, Planning, and Integration.

G.I. E13: HCC Foundations: Diagnosis, Liver Function, Staging, and Multidisciplinary Selection.

G.I. E12: Pancreas Planning Workshop: Simulation, Targets, Motion, and Constraints.

G.I. E11: Locally Advanced Pancreas: Chemotherapy, Chemoradiation, SBRT, and Adaptation.

G.I. E10: Resectable and Borderline-Resectable Pancreas: Perioperative Strategy.

G.I. E09: Pancreatic Cancer: Workup, Anatomy, Staging, and Resectability.

G.I. E08: Metastatic Gastric and GEJ Cancer: Biomarkers, Systemic Therapy, and Palliation.

G.I. E07: Gastric Radiation: Indications, Evidence, and Treatment Planning.

G.I. E06: Gastric Cancer Foundations: Staging, Surgery, and Perioperative Therapy.

G.I. E05: Adjuvant Therapy, Active Surveillance, and Advanced Esophageal Cancer.

G.I. E04: Definitive Esophageal Chemoradiation: Dose, Technique, Response, and Salvage.

G.I. E03:Resectable Esophageal and GEJ Cancer: CROSS, FLOT, and Perioperative Selection.

G.I. E02: Esophageal and GEJ Cancer Anatomy, Workup, Staging, and Surgery.

G.I. E01: Foundations, Workup, Intent, Planning Safety, and Cross Cutting Toxicity

Thoracic E30: Comprehensive Thoracic Mock Oral Review

Thoracic E29: Thoracic Oncology Board Synthesis

Thoracic E28: Thoracic Reirradiation and Cumulative Dose

Thoracic E27: Thoracic Toxicity: Prevention, Recognition, and Differential Diagnosis

Thoracic E26: Pleural Mesothelioma

Thoracic E25: Thymic Malignancies and Selected Rare Thoracic Tumors

Thoracic E24: Thoracic Palliation and Oncologic Emergencies

Thoracic E23: Oligometastatic and Oligoprogressive Non-Small-Cell Lung Cancer

Thoracic E22: Metastatic Non-Small-Cell Lung Cancer and Radiation Therapy–Systemic Therapy Integration

Thoracic E21: Stage III Non-Small Cell Lung Cancer and Small Cell Lung Cancer Mock Oral

Thoracic E20: Extensive-Stage Small Cell Lung Cancer and Thoracic Radiation

Thoracic E19: PCI, MRI Surveillance, and Hippocampal Avoidance

Thoracic E18: Limited-Stage Small Cell Lung Cancer: Timing, Planning, and Consolidation

Thoracic E17: SCLC Foundations and Curative Treatment

Thoracic E16: After Definitive CRT: Consolidation, Toxicity, and Relapse

Thoracic E15: Stage Three Targeting and Treatment Planning

Thoracic E14: Definitive Stage Three Management

Thoracic E13: Localized and Resectable Non-Small Cell Lung Cancer Mock Oral

Thoracic E12: PORT: Evidence, Selection, and Planning

Thoracic E11: Trimodality Therapy and Superior Sulcus Tumors

Thoracic E10: Resectable Stage II Through III Non-Small Cell Lung Cancer

Thoracic E09: Post-SBRT Imaging, Recurrence, and Salvage

Thoracic E08: High-Risk Early-Stage NSCLC: Central Tumors, Large Lesions, and ILD

Thoracic E07: Peripheral Lung SBRT

Thoracic E06: Early-Stage Non-Small Cell Lung Cancer Treatment Selection

Thoracic E05: Simulation, Respiratory Motion, and Image Guidance

Thoracic E04: Operability, Resectability, and Surgical Principles

Thoracic E03: Nodal Anatomy and Invasive Mediastinal Staging

Thoracic E02: Thoracic Imaging and TNM Staging

Thoracic E01: Screening, Pulmonary Nodules, and Tissue Diagnosis

GU E32: Mock Oral Boards Penile and Urethral Cancer, Node-Positive and Preservation Cases

GU E27: Case-Based Review RCC Mock Oral: Solitary Kidney, IVC, and Oligoprogression

GU E23: Testicular Mock Oral - Stage I, Stage IIA, and NSGCT Variants

GU E18: Bladder Mock Oral - trimodality therapy, post-cystectomy radiation, and local recurrence

GU E12: Case-Based Review: Prostate Cancer Mock Oral Boards

GU E31: Penile and Urethral Planning Workshop

GU E30: Penile Cancer Primary Management, Nodes & Organ Preservation

GU E29:Urethral Cancer Staging and Multimodality Management.

GU E28:Upper Tract Urothelial Carcinoma

GU E26: RCC Planning Workshop Primary and Metastatic SBRT Cases

GU E25: RCC: Oligometastatic Disease, the ICI Era, and Cytoreduction

GU E24:RCC: Localized Disease, Surgery, Ablation & Primary SBRT

GU E22:Testicular: Fertility, Toxicity, Follow-up & Failure Patterns

GU E21: Testicular: Advanced GCT, Residual Masses, and Salvage Strategy

GU E20:Testicular Stage II Seminoma, NSGCT, and Field Design

GU E19: Testicular Cancer Workup, Markers, Staging, and Stage I Seminoma

GU E17: Metastatic urothelial cancer, immunotherapy, and future directions

GU E16: Bladder Post-Cystectomy Radiation, Follow-Up, and Salvage Pathways.

GU E15: Bladder Planning Workshop Definitive Preservation Cases

GU E14: Bladder Trimodality Therapy, Radiosensitizers, and Hypofractionation.

GU E13: Bladder Cancer NMIBC, MIBC Workup and the Surgical Backbone

GU E11: Prostate Follow-up, Toxicity, Survivorship, and Failure Patterns

GU E10: Prostate Planning Workshop intact, post-op, and nodal cases

GU 09: Prostate mHSPC, CRPC, MDT, and Precision Systemic Therapy

GU E08:Prostate Salvage After Surgery, RT, and Focal Therapy

GU E04: Prostate Definitive EBRT, Dose Escalation & Moderate Hypofractionation

GU E07

GU E06

GU E05

GU E03

GU E02

GU E01: Prostate Anatomy, Pathology, Risk Groups & Natural History

H&N E39A: Sinonasal II Maxillary and Ethmoid SCC and SNUC Management

H&N E38A: Sinonasal I Anatomy, Histology Diversity, and Multimodality Logic

H&N E37B: Salivary Gland Capstone Mock Oral Board Review

H&N E37A: Salivary Gland IV Unresectable Disease and Advanced Approaches

H&N E36: Salivary Gland III Perineural Invasion and Named Nerve Strategy

H&N E35: Salivary Gland II — Adjuvant RT Triggers and Planning

H&N E34: Salivary Gland I — Histology-Driven Biology and the Surgical Paradigm

H&N E33: Hypopharynx Integration Decision Points and Surveillance